Functional Recovery, Oncologic Outcomes and Postoperative Complications after Robot-Assisted Radical Prostatectomy: An Evidence-Based Analysis Comparing the Retzius Sparing and Standard Approaches
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
We report a 1-year update of functional urinary and sexual recovery, oncologic outcomes
and postoperative complications in patients who completed a randomized controlled
trial comparing posterior (Retzius sparing) with anterior robot-assisted radical prostatectomy.
Importance: Patients diagnosed with localized prostate cancer have to decide among treatment strategies that may differ in their likelihood of adverse effects. Objective: To compare quality of life (QOL) after radical prostatectomy, external beam radiotherapy and brachytherapy vs. active surveillance. Design/Setting/Participants: Population-based prospective cohort of 1,141 men with newly-diagnosed prostate cancer were enrolled from January 2011 through June 2013 in collaboration with the North Carolina Central Cancer Registry (Rapid Case Ascertainment). 57% of eligible men enrolled. Median time from diagnosis to enrollment was 5 weeks, and all men were enrolled with written informed consent prior to treatment. Final follow-up date for current analysis was September 9, 2015. Exposure: Treatment – radical prostatectomy, external beam radiotherapy, brachytherapy, or active surveillance. Main Outcomes and Measures: Quality of life using the validated instrument Prostate Cancer Symptom Indices was assessed at baseline (pre-treatment), and 3, 12, 24 months after treatment. The instrument contains 4 domains – sexual dysfunction, urinary obstruction and irritation, urinary incontinence, and bowel problems – each scored from 0 (no dysfunction) to 100 (maximum dysfunction). Propensity-weighted mean domain scores were compared between each treatment group vs. active surveillance at each time point. Results: 314 men pursued active surveillance (27.5%), 249 external beam radiotherapy (21.8%), 109 brachytherapy (9.6%), and 469 radical prostatectomy (41.1%). After propensity weighting, median age was 66-67 years across groups, and 77-80% were white. Propensity-weighted baseline sexual dysfunction scores were 41.8-46.4 across groups, urinary obstruction and irritation 20.8-22.8, urinary incontinence 9.7-10.5, and bowel problems 5.7-6.1. Compared to active surveillance, mean sexual dysfunction scores worsened by 3 months for radical prostatectomy (+36.2 points, 95% CI 30.4-42.0), external beam radiotherapy (+13.9, 95% CI 6.7-21.2) and brachytherapy (+17.1, 95% CI 7.8-26.6) patients. Brachytherapy (+20.5 vs. active surveillance, 95% CI 15.1-25.9) and external beam radiotherapy (+11.7, 95% CI 8.7-14.8) were associated with acute worsening of urinary obstruction and irritation, radical prostatectomy (+33.6, 95% CI 27.8-39.2) with urinary incontinence, and external beam radiotherapy (+4.9, 95% CI 2.4-7.4) bowel symptoms. By 24 months, mean scores between treatment groups vs. active surveillance were not significantly different in most domains. Conclusions and Relevance: In this cohort of men with localized prostate cancer, each treatment strategy was associated with distinct patterns of adverse effects over 2 years. These findings should be used to promote treatment decisions that incorporate individual preferences.
[1
]Department of Urology, Wayne State University School of Medicine, Detroit, Michigan
[2
]Department of Urology, Case Western Reserve University, Cleveland, Ohio
[3
]Department of Urology, University of Toledo, Toledo, Ohio
[4
]Vattikuti Urology Institute Center for Outcomes Research, Analytics and Evaluation,
Vattikuti Urology Institute, Henry Ford Health System, Detroit, Michigan
[5
]Department of Urology, University of Michigan Medical School, Ann Arbor, Michigan
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.